Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iovance Biotherapeutics (IOVA) Raw Materials (2024 - 2025)

Historic Raw Materials for Iovance Biotherapeutics (IOVA) over the last 2 years, with Q1 2025 value amounting to $37.9 million.

  • Iovance Biotherapeutics' Raw Materials rose 58113.55% to $37.9 million in Q1 2025 from the same period last year, while for Mar 2025 it was $37.9 million, marking a year-over-year increase of 58113.55%. This contributed to the annual value of $27.7 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q1 2025, Iovance Biotherapeutics' Raw Materials is $37.9 million, which was up 58113.55% from $27.7 million recorded in Q4 2024.
  • Over the past 5 years, Iovance Biotherapeutics' Raw Materials peaked at $37.9 million during Q1 2025, and registered a low of $5.6 million during Q1 2024.